Infection Control Today

Study Offers New Information for the Fight Against Influenza

Ralph Tripp is the Georgia Research Alliance Eminent Scholar in Vaccine Development in the UGA College of Veterinary Medicine. The influenza virus can rapidly evolve from one form to another, complicating the effectiveness of vaccines and antiviral drugs used to treat it. ...More

2 weeks ago

Posted in News

Research Provides Unprecedented Insight into First Line of Defense in Fighting Viral Infections

Principal investigators of the study, "Structural basis of RNA recognition and activation by innate immune receptor RIG-I," chosen for advanced online publication in Nature, say the research is key in the development of broad-based drug therapies to combat viral ...More

September 29, 2011

Posted in News

Students Study Neuraminidase-sialic Acid Interactions in Combating Flu

Influenza viruses spread quickly, are quite common and can have devastating consequences. Thus, drugs that help restrict the spread of influenza not only shorten the sickness, but save lives. This summer three Hamilton College students are conducting research under ...More

July 25, 2011

Posted in News, Infections & Pathogens

New Approach to Influenza's Antiviral Resistance

Researchers from the University of California, Irvine, with assistance from the San Diego Supercomputer Center at UC San Diego, have found a new approach to the creation of customized therapies for virulent flu strains that resist current antiviral drugs. The findings, ...More

July 13, 2011

Posted in News, Infections & Pathogens

Concentration Lowered in Tamiflu Medication

When influenza season arrives this fall, a liquid form of Tamiflu—the most widely used antiviral flu medication—will be available in a new, lower concentration to reduce the possibility of medication errors, according to an announcement today by the Food and Drug ...More

July 13, 2011

Posted in News, Infections & Pathogens

Study Points to New Means of Overcoming Antiviral Resistance in Influenza

UC Irvine researchers have found a new approach to the creation of customized therapies for virulent flu strains that resist current antiviral drugs. Using powerful computer simulations, UCI’s Rommie Amaro and Robin Bush created a method to predict how pocket structures on ...More

July 12, 2011

Posted in News, Infections & Pathogens

Arrival of Direct Antiviral Agent Therapy for Hepatitis C Sparks Debate of Who to Treat First

For many patients with the hepatitis C virus (HCV), direct antiviral agents (DAA) offer a potential cure for the disease. The Food and Drug Administration (FDA) has recently approved two new DAAs, telaprevir and boceprevir, and with that clinicians must now decide who ...More

May 25, 2011

Posted in News

FDA Approves Incivek for Hepatitis C

The Food and Drug Administration (FDA) announces that it has approved Incivek (telaprevir) to treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not ...More

May 23, 2011

Posted in News

FDA Approves New HIV Treatment

The Food and Drug Administration (FDA) announces that it has approved Edurant (rilpivirine) in combination with other antiretroviral drugs for the treatment of HIV-1 infection in adults who have never taken HIV therapy (treatment-naïve). Edurant belongs to a class of HIV ...More

May 20, 2011

Posted in News

Agreement Improves Global Preparedness for Influenza Pandemics

A working group coordinated by the World Health Organization (WHO) has reached agreement on a framework to ensure that in a pandemic, influenza virus samples will be shared with partners who need the information to take steps to protect public health. The framework will ...More

April 19, 2011

Posted in News

ANTIMICROBIAL PRODUCTS	DISINFECTION/STERILIZA...
DISPOSABLE PRODUCTS	INFECTION CONTROL
LATEX-FREE PRODUCTS	More Options...

Antivirals

Galleries

ICT Poll

Most Popular Articles

Buyer's Guide

Resources

Free Email Updates

featured links

First Name	Last Name
E-Mail